NL-OMON23268尚未招募不适用
Translational research for immune modulating and targeted therapy in advanced or metastatic non-small cell lung cancer, an exploratory NVALT study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- VALT
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Eligible for immunotherapy or targeted treatment.
- •2.Written informed consent for registry of patient data and extra blood and tumor biopsy.
排除标准
- •1.Without written informed consent patient will be adopted anonymously in the registry and will not take part of the study.
- •2.Patients with written informed consent for registry of patient data but no consent for extra blood and tumor biopsy will be excluded from the study.
研究者
相似试验
尚未招募
Unknown
EFFECT Trial: Evaluating Fermentable Fibre as a Long COVID TherapyACTRN12624000356561Monash University40
已完成
不适用
ipid emulsion (drug) in Acute on Chronic Liver Failure (Liver Disease).CTRI/2018/04/012995Institute of liver and Biliary Sciences90
尚未招募
2 期
bachhon ki rog pratirodhak kshmata par swarna yukta lehan ka prabhavCTRI/2021/10/037222Shri Narayan Prasad Awasthi Government Ayurved College Raipur Chhattisgarh
尚未招募
不适用
NVALT2017 / Translational research for immune modulating and targeted therapy in non-small cell lung cancer, an exploratory NVALT studyNon-small cell lung cancerNL-OMON45514niversitair Medisch Centrum Groningen300
已完成
不适用
Development of a personalized immune-modulating therapy for patients with atopic dermatitis: evaluation of clinical efficacy of autologous immunoglobulin therapy for atopic dermatitis: a randomized, double-blind, placebo-controlled studyDiseases of the skin and subcutaneous tissueKCT0001597Ajou University Hospital51